During Monday's "Mad Money," a caller in the show's "Lightening Round" asked host Jim Cramer about Teladoc (TDOC) .
"This is seen as a stay-at-home stock. Buy more on weakness," was Cramer's advice.




During Monday's "Mad Money," a caller in the show's "Lightening Round" asked host Jim Cramer about Teladoc (TDOC) .
"This is seen as a stay-at-home stock. Buy more on weakness," was Cramer's advice.
These recently downgraded names are displaying both quantitative and technical deterioration.
Here's an options play on this small pharma name that just scored an FDA win.
Let's look a how to adjust trading techniques to fit the changes in the market.
The small caps and the Dow finally host the party on Wall Street. But will this broadening action continue?
Here's where the charts show this chipmaker heading.
We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.
Email Real Money's Wall Street Pros for further analysis and insight
Already a Subscriber? Login
Follow Real Money's Wall Street Pros to receive real-time investing alerts
Already a Subscriber? Login